- Home
- AVNS vs DIAX Comparison
AVNS vs DIAX Comparison
Compare AVNS & DIAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVNS
- DIAX
- Stock Information
- Founded
- AVNS 2014
- DIAX 2005
- Country
- AVNS United States
- DIAX United States
- Employees
- AVNS N/A
- DIAX N/A
- Industry
- AVNS Industrial Specialties
- DIAX Finance Companies
- Sector
- AVNS Health Care
- DIAX Finance
- Exchange
- AVNS Nasdaq
- DIAX Nasdaq
- Market Cap
- AVNS 591.9M
- DIAX 521.1M
- IPO Year
- AVNS N/A
- DIAX N/A
- Fundamental
- Price
- AVNS $11.70
- DIAX $14.65
- Analyst Decision
- AVNS
- DIAX
- Analyst Count
- AVNS 0
- DIAX 0
- Target Price
- AVNS N/A
- DIAX N/A
- AVG Volume (30 Days)
- AVNS 785.5K
- DIAX 96.6K
- Earning Date
- AVNS 08-05-2025
- DIAX 01-01-0001
- Dividend Yield
- AVNS N/A
- DIAX 7.93%
- EPS Growth
- AVNS N/A
- DIAX N/A
- EPS
- AVNS N/A
- DIAX N/A
- Revenue
- AVNS $692,500,000.00
- DIAX N/A
- Revenue This Year
- AVNS N/A
- DIAX N/A
- Revenue Next Year
- AVNS $3.42
- DIAX N/A
- P/E Ratio
- AVNS N/A
- DIAX N/A
- Revenue Growth
- AVNS 1.48
- DIAX N/A
- 52 Week Low
- AVNS $9.30
- DIAX $12.80
- 52 Week High
- AVNS $25.36
- DIAX $15.12
- Technical
- Relative Strength Index (RSI)
- AVNS 55.78
- DIAX 65.47
- Support Level
- AVNS $11.12
- DIAX $14.44
- Resistance Level
- AVNS $11.57
- DIAX $14.58
- Average True Range (ATR)
- AVNS 0.58
- DIAX 0.11
- MACD
- AVNS 0.12
- DIAX 0.02
- Stochastic Oscillator
- AVNS 99.17
- DIAX 92.34
About AVNS Avanos Medical Inc.
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.
About DIAX Nuveen Dow 30SM Dynamic Overwrite Fund of Beneficial Interest
Nuveen Dow 30sm Dynamic Overwrite Fund is a non-diversified closed-end management investment company. Its investment objective is to seek attractive total return with less volatility than the Dow Jones Industrial Average by investing in an equity portfolio that seeks to substantially replicate the price movements of the DJIA, as well as selling call options on 35%-75% of the notional value of the Fund's equity portfolio.